St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy

Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.) Galera (NASDAQ: GRTX) is developing proprietary therapies that have the…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news